Medicare Enrolled
Dr. Roshan George, MD
Retina Specialist (Ophthalmology) Physician · Texarkana, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. George from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. George?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. George
Dr. Roshan George is a retina specialist physician in Texarkana, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. George performed 17,851 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. George received a total of $3,253 from 21 pharmaceutical and/or device companies across 110 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. George is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 23% volume in TX
$3,253 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,851
Medicare services
Top 23% in TX for retina specialist (ophthalmology) physician
Not available
Unique patients (not deduplicated)
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
10,620 | $29 | $50 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,034 | $29 | $100 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,358 | $91 | $208 |
| Extended exam of back of eye with optic nerve drawing A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing. |
956 | $11 | $32 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
811 | $87 | $270 |
| Aflibercept eye injection (Eylea) | 544 | $688 | $1,293 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
375 | $18 | $60 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
324 | $21 | $28 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
231 | $159 | $285 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
180 | $108 | $266 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
166 | $214 | $400 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
35 | $34 | $275 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
30 | $26 | $136 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
21 | $8 | $20 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
18 | $20 | $66 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
17 | $3 | $26 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
17 | $5 | $23 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
17 | $100 | $281 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
16 | $70 | $145 |
| Removal of retinal membrane A surgical procedure to remove a membrane from the surface of the retina. |
15 | $868 | $2,185 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
15 | $8 | $48 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
14 | $8 | $88 |
| Vitreous removal between lens and retina This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye. |
13 | $645 | $3,650 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
13 | $782 | $2,150 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
11 | $181 | $1,518 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,253
Total received (2019-2024)
Avg $542/year across 6 years
Top 47% in TX for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
110
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,307
2023
$727
2022
$394
2021
$343
2020
$259
2019
$222
Payments by company (2024)
Alimera Sciences, Inc.
$365
BIOTISSUE HOLDINGS INC.
$161
ABBVIE INC.
$146
Astellas Pharma US Inc
$139
Apellis Pharmaceuticals, Inc.
$125
Bausch & Lomb Americas Inc.
$120
Sandoz Inc.
$94
Coherus Biosciences Inc.
$47
Oyster Point Pharma, Inc.
$27
Genentech USA, Inc.
$25
RxSight Inc
$21
Rayner Intraocular Lenses Limited
$19
Tarsus Pharmaceuticals, Inc.
$17
Top 3 companies account for 51.4% of 2024 payments
All-time payments by company (2019-2024) ›
ABBVIE INC.
$621
Alimera Sciences, Inc.
$505
Allergan, Inc.
$237
Genentech USA, Inc.
$235
Astellas Pharma US Inc
$200
Alcon Vision LLC
$178
Mallinckrodt Hospital Products Inc.
$165
BIOTISSUE HOLDINGS INC.
$161
Apellis Pharmaceuticals, Inc.
$142
Bausch & Lomb Americas Inc.
$137
Coherus Biosciences Inc.
$135
Novartis Pharmaceuticals Corporation
$111
Sandoz Inc.
$94
Oyster Point Pharma, Inc.
$91
Aerie Pharmaceuticals, Inc.
$59
Rayner Intraocular Lenses Limited
$58
RxSight Inc
$40
Bausch & Lomb, a division of Bausch Health US, LLC
$33
Kala Pharmaceuticals, Inc.
$18
Tarsus Pharmaceuticals, Inc.
$17
Omeros Corporation
$17
Top 3 companies account for 41.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · AcrySof IQ PanOptix · Cimerli · DURYSTA · INVELTYS · Izervay · LOTEMAX SM · LUMIGAN · LenSx · Lucentis · MIEBO · OZURDEX · Omidria · RXSIGHT CONTACT LENS · SUSVIMO · Simbrinza · Syfovre · TYRVAYA · VABYSMO · VISUDYNE · VYZULTA · Vabysmo · XDEMVY · XIIDRA · YUTIQ · rhopressa · rocklatan
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Retina specialist physicians in nearby ZIP areas
1
County median income
$59,295
Nearest hospital to ZIP centroid (approximate)
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. George is a mixed practice specialist, with above-average Medicare volume (top 23% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. George experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. George performed 10,620 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. George receive payments from pharmaceutical companies?
Yes. Dr. George received a total of $3,253 from 21 companies across 110 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. George's costs compare to other retina specialist physicians in Texarkana?
Dr. George's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. George) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Retina Specialist Physicians in Texarkana
Browse retina specialist physicians in Texarkana ranked by procedure volume and transparency data.
Highest volume
Top Retina Specialist Physicians in TX
Retina specialist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Retina Specialist Physicians in TX
Which TX retina specialist physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Alimera Sciences, Inc. Payments to Doctors
See all physicians who received payments from Alimera Sciences, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology